Patent · US Active

Method of administering amantadine prior to a sleep period

US9867791B2 · kind B2 · utility

16Cited by

114References

56Claims

0Family size

Assignee

Adamas Pharma, LLC · US

Inventors

Gregory T. Went · Mill Valley, US
Gayatri Sathyan · Bengaluru, IN
Kavita Vermani · Fremont, US
Gangadhara Ganapati · Palo Alto, US
Michael Coffee · Easton, US
Efraim Shek · Pleasanton, US
Ashok Katdare · Berkeley, US

Key dates

Filing date	Feb 9, 2017
Grant date	Jan 16, 2018
Priority date	—
Expiry date	Feb 9, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.